Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Application of Contrast-Enhanced Ultrasound in the Diagnosis of Ductal Carcinoma In Situ: Analysis of 127 Cases.

Li W, Zhou Q, Xia S, Wu Y, Fei X, Wang Y, Tao L, Fan J, Zhou W.

J Ultrasound Med. 2019 Jun 17. doi: 10.1002/jum.15069. [Epub ahead of print]

PMID:
31206200
2.

Contrast-enhanced ultrasonographic findings of different histopathologic types of breast cancer.

Wang X, Xu P, Wang Y, Grant EG.

Acta Radiol. 2011 Apr 1;52(3):248-55. doi: 10.1258/ar.2010.100279. Epub 2011 Mar 3.

PMID:
21498359
3.

Qualitative, quantitative and combination score systems in differential diagnosis of breast lesions by contrast-enhanced ultrasound.

Wang Y, Fan W, Zhao S, Zhang K, Zhang L, Zhang P, Ma R.

Eur J Radiol. 2016 Jan;85(1):48-54. doi: 10.1016/j.ejrad.2015.10.017. Epub 2015 Oct 31.

PMID:
26724648
4.

Papillary breast lesions on contrast-enhanced ultrasound: morphological enhancement patterns and diagnostic strategy.

Xia HS, Wang X, Ding H, Wen JX, Fan PL, Wang WP.

Eur Radiol. 2014 Dec;24(12):3178-90. doi: 10.1007/s00330-014-3375-7. Epub 2014 Aug 23.

PMID:
25149297
5.

MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?

Hahn SY, Han BK, Ko EY, Shin JH, Hwang JY, Nam M.

Acta Radiol. 2013 Sep;54(7):742-8. doi: 10.1177/0284185113484640. Epub 2013 Apr 30.

PMID:
23588154
6.

Role of transvaginal contrast-enhanced ultrasound in the early diagnosis of endometrial carcinoma.

Liu Y, Tian JW, Xu Y, Cheng W.

Chin Med J (Engl). 2012 Feb;125(3):416-21.

PMID:
22490395
7.

Diffusion-tensor imaging as an adjunct to dynamic contrast-enhanced MRI for improved accuracy of differential diagnosis between breast ductal carcinoma in situ and invasive breast carcinoma.

Wang Y, Zhang X, Cao K, Li Y, Li X, Qi L, Tang L, Wang Z, Gao S.

Chin J Cancer Res. 2015 Apr;27(2):209-17. doi: 10.3978/j.issn.1000-9604.2015.03.04.

8.

Ductal carcinoma in situ: is there a role for MRI?

Zuiani C, Francescutti GE, Londero V, Zunnui I, Bazzocchi M.

J Exp Clin Cancer Res. 2002 Sep;21(3 Suppl):89-95.

PMID:
12585661
10.

Application of contrast-enhanced ultrasound in the diagnosis of small breast lesions.

Du YR, Wu Y, Chen M, Gu XG.

Clin Hemorheol Microcirc. 2018;70(3):291-300. doi: 10.3233/CH-170368.

PMID:
29710688
11.

In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.

Rahbar H, Partridge SC, Demartini WB, Gutierrez RL, Allison KH, Peacock S, Lehman CD.

Radiology. 2012 May;263(2):374-82. doi: 10.1148/radiol.12111368.

12.

In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.

Viehweg P, Lampe D, Buchmann J, Heywang-Köbrunner SH.

MAGMA. 2000 Dec;11(3):129-37.

PMID:
11154954
13.

A Prospective Study on the Value of Ultrasound Microflow Assessment to Distinguish Malignant from Benign Solid Breast Masses: Association between Ultrasound Parameters and Histologic Microvessel Densities.

Park AY, Kwon M, Woo OH, Cho KR, Park EK, Cha SH, Song SE, Lee JH, Cha J, Son GS, Seo BK.

Korean J Radiol. 2019 May;20(5):759-772. doi: 10.3348/kjr.2018.0515.

14.

Diagnostic and prognostic values of contrast-enhanced ultrasound in breast cancer: a retrospective study.

Zhao YX, Liu S, Hu YB, Ge YY, Lv DM.

Onco Targets Ther. 2017 Feb 22;10:1123-1129. doi: 10.2147/OTT.S124134. eCollection 2017.

15.

Breast ductal carcinoma in situ: morphologic and kinetic MRI findings.

Nadrljanski MM, Marković BB, Milošević ZČ.

Iran J Radiol. 2013 Jun;10(2):99-102. doi: 10.5812/iranjradiol.4876. Epub 2013 May 20.

16.

Association between enhancement patterns and parameters of contrast-enhanced ultrasound and microvessel distribution in breast cancer.

Li X, Li Y, Zhu Y, Fu L, Liu P.

Oncol Lett. 2018 Apr;15(4):5643-5649. doi: 10.3892/ol.2018.8078. Epub 2018 Feb 16.

17.

Sonographic Features of Ductal Carcinoma In Situ of the Breast With Microinvasion: Correlation With Clinicopathologic Findings and Biomarkers.

Yao JJ, Zhan WW, Chen M, Zhang XX, Zhu Y, Fei XC, Chen XS.

J Ultrasound Med. 2015 Oct;34(10):1761-8. doi: 10.7863/ultra.15.14.07059. Epub 2015 Aug 31.

PMID:
26324758
18.

Contrast-enhanced ultrasound for detection and diagnosis of renal clear cell carcinoma.

Dong XQ, Shen Y, Xu LW, Xu CM, Bi W, Wang XM.

Chin Med J (Engl). 2009 May 20;122(10):1179-83.

PMID:
19493467
19.

[Value of contrast-enhanced ultrasound (CEUS) in the differential diagnosis between benign and malignant renal neoplasms].

Zhang S, Wang XQ, Xin XJ, Xu Y.

Zhonghua Zhong Liu Za Zhi. 2013 May;35(5):382-5. doi: 10.3760/cma.j.issn.0253-3766.2013.05.013. Chinese.

PMID:
24054017
20.

Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging.

Ricci P, Cantisani V, Ballesio L, Pagliara E, Sallusti E, Drudi FM, Trippa F, Calascibetta F, Erturk SM, Modesti M, Passariello R.

Ultraschall Med. 2007 Feb;28(1):57-62.

PMID:
17304413

Supplemental Content

Support Center